Myocardial bridging increases the risk of coronary spasm

Background: Myocardial bridging (MB) has been associated with cardiac events. Whether coronary spasm is one factor contributing to those events is unknown. Hypothesis: This study investigated whether the likelihood of coronary spasm is increased in patients with MB. Methods: A spasm‐provocation test...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical cardiology (Mahwah, N.J.) N.J.), 2003-08, Vol.26 (8), p.377-383
Hauptverfasser: Teragawa, Hiroki, Fukuda, Yukihiro, Matsuda, Keiji, Hirao, Hidekazu, Higashi, Yukihito, Yamagata, Togo, Oshima, Tetsuya, Matsuura, Hideo, Chayama, Kazuaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 383
container_issue 8
container_start_page 377
container_title Clinical cardiology (Mahwah, N.J.)
container_volume 26
creator Teragawa, Hiroki
Fukuda, Yukihiro
Matsuda, Keiji
Hirao, Hidekazu
Higashi, Yukihito
Yamagata, Togo
Oshima, Tetsuya
Matsuura, Hideo
Chayama, Kazuaki
description Background: Myocardial bridging (MB) has been associated with cardiac events. Whether coronary spasm is one factor contributing to those events is unknown. Hypothesis: This study investigated whether the likelihood of coronary spasm is increased in patients with MB. Methods: A spasm‐provocation test was performed by infusing acetylcholine into the left coronary artery in 114 Japanese patients with chest pain. The test result was defined as positive when the diameter of the coronary artery was reduced by > 50% and ST‐segment changes were documented. Myocardial bridging was defined as a > 15% reduction in coronary arterial diameter during systole after intracoronary injection of nitroglycerin. Results: Myocardial bridging was identified in 41 patients (36%) and was located in the mid‐segment of the left anterior descending coronary artery (LAD) in all patients. Patients with MB experienced coronary spasm more frequently than patients without MB (MB+: 73%; MB —: 40%, p = 0.0006). Furthermore, among patients with a positive spasm‐provocation test, coronary spasm occurred more frequently in the midsegment of the LAD in patients with MB than in those without MB (MB+: 73%; MB — : 45%, p = 0.0259). Multivariate regression analysis demonstrated that MB was a predictor of coronary spasm (odds ratio: 3.478, p = 0.0088). Conclusions: These results suggest that MB increases the risk of coronary spasm and that coronary spasm may be the proximate etiology of cardiac events associated with MB.
doi_str_mv 10.1002/clc.4950260806
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6653965</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73579344</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5326-39f41b8238c0806b895115b3117fcbf066c98ed9fddeb8f846132bdb72dba6733</originalsourceid><addsrcrecordid>eNqFkDtPwzAUhS0EoqWwMqIssKX4kTj2goQiXlIRC8yW7ditIY2L3YL673HViJaJ4eoO97vnHB0AzhEcIwjxtW71uOAlxBQySA_AEHGCc1aR6hAMIaIw55jxATiJ8T3xkGFyDAYIc8RoAYeAPa-9lqFxss1UcM3UddPMdToYGU3MljOTBRc_Mm8z7YPvZFhncSHj_BQcWdlGc9bvEXi7v3utH_PJy8NTfTvJdUkwzQm3BVLJlelNQMV4iVCpCEKV1cpCSjVnpuG2aYxilhUUEawaVeFGSVoRMgI3W93FSs1No023DLIVi-DmKYvw0om_l87NxNR_CUpLwtOMwFUvEPznysSlmLuoTdvKzvhVFBUpK06KIoHjLaiDjzEY-2uCoNiULVLZYld2erjYj7bD-3YTcNkDMmrZ2iA77eKOS0oV5ThxfMt9u9as_7EV9aTeC_EDfO-YwQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73579344</pqid></control><display><type>article</type><title>Myocardial bridging increases the risk of coronary spasm</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Teragawa, Hiroki ; Fukuda, Yukihiro ; Matsuda, Keiji ; Hirao, Hidekazu ; Higashi, Yukihito ; Yamagata, Togo ; Oshima, Tetsuya ; Matsuura, Hideo ; Chayama, Kazuaki</creator><creatorcontrib>Teragawa, Hiroki ; Fukuda, Yukihiro ; Matsuda, Keiji ; Hirao, Hidekazu ; Higashi, Yukihito ; Yamagata, Togo ; Oshima, Tetsuya ; Matsuura, Hideo ; Chayama, Kazuaki</creatorcontrib><description>Background: Myocardial bridging (MB) has been associated with cardiac events. Whether coronary spasm is one factor contributing to those events is unknown. Hypothesis: This study investigated whether the likelihood of coronary spasm is increased in patients with MB. Methods: A spasm‐provocation test was performed by infusing acetylcholine into the left coronary artery in 114 Japanese patients with chest pain. The test result was defined as positive when the diameter of the coronary artery was reduced by &gt; 50% and ST‐segment changes were documented. Myocardial bridging was defined as a &gt; 15% reduction in coronary arterial diameter during systole after intracoronary injection of nitroglycerin. Results: Myocardial bridging was identified in 41 patients (36%) and was located in the mid‐segment of the left anterior descending coronary artery (LAD) in all patients. Patients with MB experienced coronary spasm more frequently than patients without MB (MB+: 73%; MB —: 40%, p = 0.0006). Furthermore, among patients with a positive spasm‐provocation test, coronary spasm occurred more frequently in the midsegment of the LAD in patients with MB than in those without MB (MB+: 73%; MB — : 45%, p = 0.0259). Multivariate regression analysis demonstrated that MB was a predictor of coronary spasm (odds ratio: 3.478, p = 0.0088). Conclusions: These results suggest that MB increases the risk of coronary spasm and that coronary spasm may be the proximate etiology of cardiac events associated with MB.</description><identifier>ISSN: 0160-9289</identifier><identifier>EISSN: 1932-8737</identifier><identifier>DOI: 10.1002/clc.4950260806</identifier><identifier>PMID: 12918640</identifier><identifier>CODEN: CLCADC</identifier><language>eng</language><publisher>New York: Wiley Periodicals, Inc</publisher><subject>Acetylcholine - administration &amp; dosage ; Acetylcholine - pharmacology ; Angina Pectoris - complications ; Angina Pectoris - diagnosis ; Angina Pectoris - drug therapy ; Arteries - drug effects ; Biological and medical sciences ; cardiac sudden death ; Cardiology. Vascular system ; Clinical Investigation ; Clinical Investigations ; Coronary Angiography ; coronary artery ; Coronary heart disease ; Coronary Vasospasm - diagnosis ; Coronary Vasospasm - diagnostic imaging ; Coronary Vasospasm - etiology ; Coronary Vessels - drug effects ; Female ; Heart ; Humans ; Injections, Intra-Arterial ; Key words: vasospastic angina ; Male ; Medical sciences ; Middle Aged ; Nitroglycerin - administration &amp; dosage ; Predictive Value of Tests ; Risk Factors ; Ultrasonography ; Vasodilator Agents - administration &amp; dosage ; Vasodilator Agents - pharmacology</subject><ispartof>Clinical cardiology (Mahwah, N.J.), 2003-08, Vol.26 (8), p.377-383</ispartof><rights>Copyright © 2003 Wiley Periodicals, Inc.</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5326-39f41b8238c0806b895115b3117fcbf066c98ed9fddeb8f846132bdb72dba6733</citedby><cites>FETCH-LOGICAL-c5326-39f41b8238c0806b895115b3117fcbf066c98ed9fddeb8f846132bdb72dba6733</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653965/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653965/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,1411,27901,27902,45550,45551,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15027692$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12918640$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Teragawa, Hiroki</creatorcontrib><creatorcontrib>Fukuda, Yukihiro</creatorcontrib><creatorcontrib>Matsuda, Keiji</creatorcontrib><creatorcontrib>Hirao, Hidekazu</creatorcontrib><creatorcontrib>Higashi, Yukihito</creatorcontrib><creatorcontrib>Yamagata, Togo</creatorcontrib><creatorcontrib>Oshima, Tetsuya</creatorcontrib><creatorcontrib>Matsuura, Hideo</creatorcontrib><creatorcontrib>Chayama, Kazuaki</creatorcontrib><title>Myocardial bridging increases the risk of coronary spasm</title><title>Clinical cardiology (Mahwah, N.J.)</title><addtitle>Clin Cardiol</addtitle><description>Background: Myocardial bridging (MB) has been associated with cardiac events. Whether coronary spasm is one factor contributing to those events is unknown. Hypothesis: This study investigated whether the likelihood of coronary spasm is increased in patients with MB. Methods: A spasm‐provocation test was performed by infusing acetylcholine into the left coronary artery in 114 Japanese patients with chest pain. The test result was defined as positive when the diameter of the coronary artery was reduced by &gt; 50% and ST‐segment changes were documented. Myocardial bridging was defined as a &gt; 15% reduction in coronary arterial diameter during systole after intracoronary injection of nitroglycerin. Results: Myocardial bridging was identified in 41 patients (36%) and was located in the mid‐segment of the left anterior descending coronary artery (LAD) in all patients. Patients with MB experienced coronary spasm more frequently than patients without MB (MB+: 73%; MB —: 40%, p = 0.0006). Furthermore, among patients with a positive spasm‐provocation test, coronary spasm occurred more frequently in the midsegment of the LAD in patients with MB than in those without MB (MB+: 73%; MB — : 45%, p = 0.0259). Multivariate regression analysis demonstrated that MB was a predictor of coronary spasm (odds ratio: 3.478, p = 0.0088). Conclusions: These results suggest that MB increases the risk of coronary spasm and that coronary spasm may be the proximate etiology of cardiac events associated with MB.</description><subject>Acetylcholine - administration &amp; dosage</subject><subject>Acetylcholine - pharmacology</subject><subject>Angina Pectoris - complications</subject><subject>Angina Pectoris - diagnosis</subject><subject>Angina Pectoris - drug therapy</subject><subject>Arteries - drug effects</subject><subject>Biological and medical sciences</subject><subject>cardiac sudden death</subject><subject>Cardiology. Vascular system</subject><subject>Clinical Investigation</subject><subject>Clinical Investigations</subject><subject>Coronary Angiography</subject><subject>coronary artery</subject><subject>Coronary heart disease</subject><subject>Coronary Vasospasm - diagnosis</subject><subject>Coronary Vasospasm - diagnostic imaging</subject><subject>Coronary Vasospasm - etiology</subject><subject>Coronary Vessels - drug effects</subject><subject>Female</subject><subject>Heart</subject><subject>Humans</subject><subject>Injections, Intra-Arterial</subject><subject>Key words: vasospastic angina</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nitroglycerin - administration &amp; dosage</subject><subject>Predictive Value of Tests</subject><subject>Risk Factors</subject><subject>Ultrasonography</subject><subject>Vasodilator Agents - administration &amp; dosage</subject><subject>Vasodilator Agents - pharmacology</subject><issn>0160-9289</issn><issn>1932-8737</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkDtPwzAUhS0EoqWwMqIssKX4kTj2goQiXlIRC8yW7ditIY2L3YL673HViJaJ4eoO97vnHB0AzhEcIwjxtW71uOAlxBQySA_AEHGCc1aR6hAMIaIw55jxATiJ8T3xkGFyDAYIc8RoAYeAPa-9lqFxss1UcM3UddPMdToYGU3MljOTBRc_Mm8z7YPvZFhncSHj_BQcWdlGc9bvEXi7v3utH_PJy8NTfTvJdUkwzQm3BVLJlelNQMV4iVCpCEKV1cpCSjVnpuG2aYxilhUUEawaVeFGSVoRMgI3W93FSs1No023DLIVi-DmKYvw0om_l87NxNR_CUpLwtOMwFUvEPznysSlmLuoTdvKzvhVFBUpK06KIoHjLaiDjzEY-2uCoNiULVLZYld2erjYj7bD-3YTcNkDMmrZ2iA77eKOS0oV5ThxfMt9u9as_7EV9aTeC_EDfO-YwQ</recordid><startdate>200308</startdate><enddate>200308</enddate><creator>Teragawa, Hiroki</creator><creator>Fukuda, Yukihiro</creator><creator>Matsuda, Keiji</creator><creator>Hirao, Hidekazu</creator><creator>Higashi, Yukihito</creator><creator>Yamagata, Togo</creator><creator>Oshima, Tetsuya</creator><creator>Matsuura, Hideo</creator><creator>Chayama, Kazuaki</creator><general>Wiley Periodicals, Inc</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200308</creationdate><title>Myocardial bridging increases the risk of coronary spasm</title><author>Teragawa, Hiroki ; Fukuda, Yukihiro ; Matsuda, Keiji ; Hirao, Hidekazu ; Higashi, Yukihito ; Yamagata, Togo ; Oshima, Tetsuya ; Matsuura, Hideo ; Chayama, Kazuaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5326-39f41b8238c0806b895115b3117fcbf066c98ed9fddeb8f846132bdb72dba6733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Acetylcholine - administration &amp; dosage</topic><topic>Acetylcholine - pharmacology</topic><topic>Angina Pectoris - complications</topic><topic>Angina Pectoris - diagnosis</topic><topic>Angina Pectoris - drug therapy</topic><topic>Arteries - drug effects</topic><topic>Biological and medical sciences</topic><topic>cardiac sudden death</topic><topic>Cardiology. Vascular system</topic><topic>Clinical Investigation</topic><topic>Clinical Investigations</topic><topic>Coronary Angiography</topic><topic>coronary artery</topic><topic>Coronary heart disease</topic><topic>Coronary Vasospasm - diagnosis</topic><topic>Coronary Vasospasm - diagnostic imaging</topic><topic>Coronary Vasospasm - etiology</topic><topic>Coronary Vessels - drug effects</topic><topic>Female</topic><topic>Heart</topic><topic>Humans</topic><topic>Injections, Intra-Arterial</topic><topic>Key words: vasospastic angina</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nitroglycerin - administration &amp; dosage</topic><topic>Predictive Value of Tests</topic><topic>Risk Factors</topic><topic>Ultrasonography</topic><topic>Vasodilator Agents - administration &amp; dosage</topic><topic>Vasodilator Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teragawa, Hiroki</creatorcontrib><creatorcontrib>Fukuda, Yukihiro</creatorcontrib><creatorcontrib>Matsuda, Keiji</creatorcontrib><creatorcontrib>Hirao, Hidekazu</creatorcontrib><creatorcontrib>Higashi, Yukihito</creatorcontrib><creatorcontrib>Yamagata, Togo</creatorcontrib><creatorcontrib>Oshima, Tetsuya</creatorcontrib><creatorcontrib>Matsuura, Hideo</creatorcontrib><creatorcontrib>Chayama, Kazuaki</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical cardiology (Mahwah, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teragawa, Hiroki</au><au>Fukuda, Yukihiro</au><au>Matsuda, Keiji</au><au>Hirao, Hidekazu</au><au>Higashi, Yukihito</au><au>Yamagata, Togo</au><au>Oshima, Tetsuya</au><au>Matsuura, Hideo</au><au>Chayama, Kazuaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myocardial bridging increases the risk of coronary spasm</atitle><jtitle>Clinical cardiology (Mahwah, N.J.)</jtitle><addtitle>Clin Cardiol</addtitle><date>2003-08</date><risdate>2003</risdate><volume>26</volume><issue>8</issue><spage>377</spage><epage>383</epage><pages>377-383</pages><issn>0160-9289</issn><eissn>1932-8737</eissn><coden>CLCADC</coden><abstract>Background: Myocardial bridging (MB) has been associated with cardiac events. Whether coronary spasm is one factor contributing to those events is unknown. Hypothesis: This study investigated whether the likelihood of coronary spasm is increased in patients with MB. Methods: A spasm‐provocation test was performed by infusing acetylcholine into the left coronary artery in 114 Japanese patients with chest pain. The test result was defined as positive when the diameter of the coronary artery was reduced by &gt; 50% and ST‐segment changes were documented. Myocardial bridging was defined as a &gt; 15% reduction in coronary arterial diameter during systole after intracoronary injection of nitroglycerin. Results: Myocardial bridging was identified in 41 patients (36%) and was located in the mid‐segment of the left anterior descending coronary artery (LAD) in all patients. Patients with MB experienced coronary spasm more frequently than patients without MB (MB+: 73%; MB —: 40%, p = 0.0006). Furthermore, among patients with a positive spasm‐provocation test, coronary spasm occurred more frequently in the midsegment of the LAD in patients with MB than in those without MB (MB+: 73%; MB — : 45%, p = 0.0259). Multivariate regression analysis demonstrated that MB was a predictor of coronary spasm (odds ratio: 3.478, p = 0.0088). Conclusions: These results suggest that MB increases the risk of coronary spasm and that coronary spasm may be the proximate etiology of cardiac events associated with MB.</abstract><cop>New York</cop><pub>Wiley Periodicals, Inc</pub><pmid>12918640</pmid><doi>10.1002/clc.4950260806</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0160-9289
ispartof Clinical cardiology (Mahwah, N.J.), 2003-08, Vol.26 (8), p.377-383
issn 0160-9289
1932-8737
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6653965
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Acetylcholine - administration & dosage
Acetylcholine - pharmacology
Angina Pectoris - complications
Angina Pectoris - diagnosis
Angina Pectoris - drug therapy
Arteries - drug effects
Biological and medical sciences
cardiac sudden death
Cardiology. Vascular system
Clinical Investigation
Clinical Investigations
Coronary Angiography
coronary artery
Coronary heart disease
Coronary Vasospasm - diagnosis
Coronary Vasospasm - diagnostic imaging
Coronary Vasospasm - etiology
Coronary Vessels - drug effects
Female
Heart
Humans
Injections, Intra-Arterial
Key words: vasospastic angina
Male
Medical sciences
Middle Aged
Nitroglycerin - administration & dosage
Predictive Value of Tests
Risk Factors
Ultrasonography
Vasodilator Agents - administration & dosage
Vasodilator Agents - pharmacology
title Myocardial bridging increases the risk of coronary spasm
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T11%3A51%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myocardial%20bridging%20increases%20the%20risk%20of%20coronary%20spasm&rft.jtitle=Clinical%20cardiology%20(Mahwah,%20N.J.)&rft.au=Teragawa,%20Hiroki&rft.date=2003-08&rft.volume=26&rft.issue=8&rft.spage=377&rft.epage=383&rft.pages=377-383&rft.issn=0160-9289&rft.eissn=1932-8737&rft.coden=CLCADC&rft_id=info:doi/10.1002/clc.4950260806&rft_dat=%3Cproquest_pubme%3E73579344%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73579344&rft_id=info:pmid/12918640&rfr_iscdi=true